Showing 1-50 of 914 stocks
| Number | Ticker | Industry | Market Cap | Last Price | Change % | Volume |
|---|---|---|---|---|---|---|
| 1 | LLYEli Lilly and Company | Biotechnology: Pharmaceutical Preparations | $950.7B | $921.16 | +1.93% | 904.4K |
| 2 | JNJJohnson & Johnson | Biotechnology: Pharmaceutical Preparations | $589.2B | $235.59 | +0.08% | 2.2M |
| 3 | ABBVAbbVie Inc. | Biotechnology: Pharmaceutical Preparations | $400.9B | $204.73 | +0.22% | 1.5M |
| 4 | AZNAstraZeneca PLC | Biotechnology: Pharmaceutical Preparations | $285.7B | $184.65 | +0.69% | 688.4K |
| 5 | PMPhilip Morris International Inc | Medicinal Chemicals and Botanical Products | $279.3B | $164.26 | +0.95% | 836.6K |
| 6 | NVSNovartis AG | Biotechnology: Pharmaceutical Preparations | $278.6B | $147.77 | +1.33% | 499.5K |
| 7 | MRKMerck & Company Inc. (new) | Biotechnology: Pharmaceutical Preparations | $268.7B | $115.82 | +1.89% | 2.6M |
| 8 | UNHUnitedHealth Group | Medical Specialities | $250.1B | $271.54 | -2.08% | 2.4M |
| 9 | ABTAbbott Laboratories | Medical/Dental Instruments | $189.6B | $104.89 | -1.39% | 1.9M |
| 10 | AMGNAmgen Inc. | Biotechnology: Biological Products (No Diagnostic Substances) | $187.5B | $350.86 | +1.43% | 540.5K |
| 11 | GILDGilead Sciences Inc. | Biotechnology: Biological Products (No Diagnostic Substances) | $184.4B | $137.59 | +0.18% | 1.6M |
| 12 | ISRGIntuitive Surgical Inc. | Medical/Dental Instruments | $176.2B | $480.56 | +0.53% | 416.0K |
| 13 | NVONovo Nordisk A/S | Biotechnology: Biological Products (No Diagnostic Substances) | $172.5B | $36.53 | +0.26% | 5.3M |
| 14 | PFEPfizer Inc. | Biotechnology: Pharmaceutical Preparations | $155.2B | $26.74 | -0.82% | 10.3M |
| 15 | SYKStryker Corporation | Medical/Dental Instruments | $140.0B | $334.08 | -0.80% | 633.0K |
| 16 | MDTMedtronic plc. | Biotechnology: Electromedical & Electrotherapeutic Apparatus | $131.9B | $86.94 | +0.61% | 1.7M |
| 17 | BTIBritish American Tobacco Industries p.l.c. ADR | Medicinal Chemicals and Botanical Products | $130.6B | $57.47 | +0.27% | 1.7M |
| 18 | BMYBristol-Myers Squibb Company | Biotechnology: Pharmaceutical Preparations | $123.7B | $57.47 | +0.55% | 3.0M |
| 19 | HCAHCA Healthcare Inc. | Hospital/Nursing Management | $119.1B | $498.22 | +0.98% | 282.7K |
| 20 | MCKMcKesson Corporation | Other Pharmaceuticals | $115.7B | $884.57 | -0.43% | 160.7K |
| 21 | SNYSanofi ADS | Biotechnology: Pharmaceutical Preparations | $107.3B | $44.73 | +0.12% | 943.0K |
| 22 | BSXBoston Scientific Corporation | Medical/Dental Instruments | $103.6B | $69.30 | -0.65% | 3.1M |
| 23 | MOAltria Group Inc. | Medicinal Chemicals and Botanical Products | $98.6B | $64.64 | +0.51% | 3.5M |
| 24 | GSKGSK plc (Each representing two) | Biotechnology: Pharmaceutical Preparations | $96.1B | $52.12 | +0.76% | 1.3M |
| 25 | REGNRegeneron Pharmaceuticals Inc. | Biotechnology: Pharmaceutical Preparations | $77.5B | $740.32 | +0.93% | 114.5K |
| 26 | ELVElevance Health Inc. | Medical Specialities | $76.5B | $288.33 | -1.40% | 312.2K |
| 27 | MMM3M Company | Medical/Dental Instruments | $76.4B | $146.61 | +4.14% | 1.4M |
| 28 | CIThe Cigna Group | Medical Specialities | $69.3B | $261.19 | -0.68% | 356.1K |
| 29 | CORCencora Inc. | Other Pharmaceuticals | $68.5B | $321.90 | -2.04% | 246.8K |
| 30 | IDXXIDEXX Laboratories Inc. | Biotechnology: In Vitro & In Vivo Diagnostic Substances | $57.1B | $580.88 | +1.01% | 103.7K |
| 31 | TAKTakeda Pharmaceutical Company Limited (each representing 1/2 of a share of) | Biotechnology: Pharmaceutical Preparations | $56.5B | $17.85 | +0.11% | 1.1M |
| 32 | ARGXargenx SE | Biotechnology: Biological Products (No Diagnostic Substances) | $52.0B | $684.40 | +2.80% | 158.0K |
| 33 | BDXBecton Dickinson and Company | Medical/Dental Instruments | $51.5B | $156.36 | +1.18% | 441.9K |
| 34 | CAHCardinal Health Inc. | Other Pharmaceuticals | $51.2B | $208.29 | +0.12% | 428.8K |
| 35 | EWEdwards Lifesciences Corporation | Industrial Specialties | $50.2B | $82.55 | +0.01% | 957.6K |
| 36 | ZTSZoetis Inc. | Biotechnology: Pharmaceutical Preparations | $48.7B | $115.22 | -0.16% | 962.0K |
| 37 | ALNYAlnylam Pharmaceuticals Inc. | Biotechnology: Pharmaceutical Preparations | $42.1B | $305.88 | -2.24% | 386.3K |
| 38 | ALCAlcon Inc. | Ophthalmic Goods | $39.9B | $74.32 | +1.18% | 294.0K |
| 39 | MDLNMedline Inc. Class A Common Stock | Medical/Dental Instruments | $37.1B | $42.27 | +0.00% | 1.3M |
| 40 | TEVATeva Pharmaceutical Industries Limited | Biotechnology: Pharmaceutical Preparations | $36.7B | $28.90 | +0.64% | 1.2M |
| 41 | ONCBeiGene Ltd. American Depositary Shares | Biotechnology: Pharmaceutical Preparations | $33.5B | $275.37 | +0.00% | 66.7K |
| 42 | RMDResMed Inc. | Medical/Dental Instruments | $33.2B | $228.82 | +1.06% | 200.9K |
| 43 | INSMInsmed Incorporated | Biotechnology: Pharmaceutical Preparations | $30.1B | $143.52 | +4.84% | 1.5M |
| 44 | NTRANatera Inc. | Medical Specialities | $28.0B | $199.16 | +1.68% | 311.8K |
| 45 | IQVIQVIA Holdings Inc. | Biotechnology: Commercial Physical & Biological Resarch | $27.7B | $166.31 | +0.18% | 311.8K |
| 46 | BIIBBiogen Inc. | Biotechnology: Pharmaceutical Preparations | $27.1B | $184.07 | +1.59% | 150.8K |
| 47 | DXCMDexCom Inc. | Medical/Dental Instruments | $26.5B | $66.96 | +0.00% | 802.2K |
| 48 | PHGKoninklijke Philips N.V. NY Registry Shares | Medical Electronics | $25.4B | $26.87 | +2.40% | 366.4K |
| 49 | UTHRUnited Therapeutics Corporation | Biotechnology: Pharmaceutical Preparations | $23.9B | $531.10 | +1.11% | 126.4K |
| 50 | DGXQuest Diagnostics Incorporated | Medical Specialities | $23.1B | $197.33 | +0.43% | 179.8K |
This page provides a comprehensive list of stocks in the Health Care sector. The data includes market capitalization, current prices, price changes, trading volume, and industry classification.
Disclaimer: The information provided on this page is for informational purposes only and should not be considered as financial advice. Stock prices and market data are subject to change. Always conduct your own research and consult with a qualified financial advisor before making investment decisions.